Vanda Pharmaceuticals, Inc. (VNDA)
7.92
-0.28
(-3.41%)
USD |
NASDAQ |
Mar 05, 16:00
7.93
+0.01
(+0.13%)
After-Hours: 20:00
Vanda Pharmaceuticals Free Cash Flow : -110.44M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Eli Lilly & Co. | 5.964B |
| Axsome Therapeutics, Inc. | -93.88M |
| AnaptysBio, Inc. | 19.61M |
| Gossamer Bio, Inc. | -158.51M |
| Arcellx, Inc. | -212.58M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -29.42M |
| Cash from Investing (Quarterly) | 44.87M |
| Cash from Financing (Quarterly) | -0.64M |
| Free Cash Flow Per Share (Quarterly) | -0.4995 |
| Free Cash Flow to Equity (Quarterly) | -31.23M |
| Free Cash Flow to Firm (Quarterly) | -29.52M |
| Free Cash Flow Yield | -23.66% |